Profil
Leonard Scott Dove is a former Director-Compound Partnering at Pharmaceutical Product Development LLC.
He was also an Executive Director-Clinical Development at Allergan Ltd. (Ireland) from 2015 to 2017.
From 2017 to 2022, he served as the Senior Vice President & General Manager at PPD, Inc. Most recently, in 2022, he held the position of Chief Operating Officer at Aravive, Inc. Dr. Dove obtained his undergraduate and doctorate degrees from Texas A&M University.
Anciens postes connus de Leonard Dove
| Sociétés | Poste | Fin |
|---|---|---|
| ARAVIVE, INC. | Directeur des opérations | 01/08/2023 |
| PPD, INC. | Corporate Officer/Principal | 01/03/2022 |
| ALLERGAN PLC | Directeur Technique/Scientifique/R&D | 01/11/2017 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Corporate Officer/Principal | - |
Formation de Leonard Dove
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
PPD, Inc.
PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
















